Joseph Lieberman actually said...
And we were talking about the problem that there were not medical--pharmaceutical countermeasures and how do we create a market incentive where there is no natural market incentive for pharmaceutical companies to devote research to this.
Context
Lieberman highlights the lack of market incentives for pharmaceutical research after 9/11.
10/27/2015